Di Gennaro, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 1.341
AS - Asia 1.163
EU - Europa 745
SA - Sud America 191
AF - Africa 19
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.467
Nazione #
US - Stati Uniti d'America 1.294
SG - Singapore 488
CN - Cina 249
IT - Italia 160
BR - Brasile 157
SE - Svezia 114
DE - Germania 112
VN - Vietnam 102
ID - Indonesia 89
FR - Francia 75
UA - Ucraina 63
IN - India 61
GB - Regno Unito 51
FI - Finlandia 37
IE - Irlanda 36
HK - Hong Kong 31
BD - Bangladesh 28
MX - Messico 25
JP - Giappone 24
NL - Olanda 22
RU - Federazione Russa 19
AR - Argentina 17
CA - Canada 17
PK - Pakistan 17
KR - Corea 13
RO - Romania 12
IQ - Iraq 11
AT - Austria 10
TR - Turchia 10
PL - Polonia 8
BE - Belgio 7
EC - Ecuador 6
AU - Australia 5
CO - Colombia 5
EG - Egitto 5
ES - Italia 4
IR - Iran 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PH - Filippine 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GE - Georgia 2
JO - Giordania 2
KZ - Kazakistan 2
NP - Nepal 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
PE - Perù 1
PY - Paraguay 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
VI - Stati Uniti Isole Vergini 1
Totale 3.467
Città #
Singapore 294
Ashburn 162
Chandler 151
San Jose 131
Beijing 48
Ann Arbor 43
Ho Chi Minh City 42
Los Angeles 39
Redmond 39
New York 36
Dublin 35
Hanoi 34
Jacksonville 34
Jakarta 32
Hefei 29
Lauterbourg 28
Munich 28
Hong Kong 27
Rome 26
San Mateo 26
Council Bluffs 23
Dallas 23
Nanjing 23
The Dalles 22
Milan 20
São Paulo 20
Tokyo 20
Boston 19
Bremen 17
Helsinki 17
Buffalo 16
St Louis 16
Boardman 15
Hyderabad 15
Moscow 15
Santa Clara 15
Woodbridge 15
Lancaster 14
Wilmington 14
Chicago 13
Dearborn 13
Marseille 13
Redwood City 13
Frankfurt am Main 12
Seattle 12
Amsterdam 11
Bandung 10
Menlo Park 10
Mexico City 10
Poplar 9
Princeton 9
Rio de Janeiro 9
Guangzhou 8
Lawrence 8
Mountain View 8
Seoul 8
Cattolica 7
Houston 7
Kent 7
London 7
Augusta 6
Nuremberg 6
Andover 5
Brooklyn 5
Brussels 5
Bucharest 5
Da Nang 5
Denver 5
Dhaka 5
Fairfield 5
Jiaxing 5
Lahore 5
Lappeenranta 5
Rawalpindi 5
Stockholm 5
Vienna 5
Warsaw 5
Zhengzhou 5
Atlanta 4
Baghdad 4
Bari 4
Falkenstein 4
Florence 4
Guayaquil 4
Islamabad 4
Izmir 4
Mumbai 4
Naples 4
Orem 4
Ottawa 4
Paris 4
Sydney 4
Tianjin 4
Tukwila 4
University Park 4
Utrecht 4
Belo Horizonte 3
Chengdu 3
Delhi 3
Düsseldorf 3
Totale 2.003
Nome #
An old drug for a new application: carbazochrome-sodium-sulfonate in HHT. 343
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 171
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 171
An old drug for a new application: carbazochrome-sodium-sulfonate in HHT 146
Leukocyte Activation in Obese Patients: Effect of Bariatric Surgery 145
Polycythemia vera. 138
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 137
Polycythemia vera: gender-related phenotypic differences 136
Polycythemia vera:gender-related phenotypic differences 134
Prevention of thrombosis in polycythemia vera and essential thrombocythemia 130
Hemophilia A and von Willebrand deficiency: therapeutic implications 130
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 130
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 121
Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation 119
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 116
Malnutrition as a Risk Factor in the Development of Oral Cancer: A Systematic Literature Review and Meta-Analyses 116
Pathophysiology of thrombosis in myeloproliferative neoplasms 116
Effects of coagulation factors on bone cells and consequences of their absence in haemophilia a patients 115
Oral Squamous Cell Carcinoma-Associated Thrombosis: What Evidence? 108
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 107
Extended coagulation profile of children with Long Covid: a prospective study 104
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms 100
Thrombosis in myeloproliferative and myelodysplastic syndromes. 98
Circulating Activated Platelets in Children With Long Covid: A Case-Controlled Preliminary Observation 92
Direct oral anticoagulants in cancer patients: which help from the specialist hemostasis and thrombosis laboratory? 89
An integrated multitool analysis contributes elements to interpreting unclassified factor IX missense variants associated with hemophilia B 77
No Increased Risk of Thromboembolic Events During 6-Month Treatment With Baricitinib in Patients With Alopecia Areata 66
The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: Results of the prospective collaborative EPICA study 51
Natural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain 3
Totale 3.509
Categoria #
all - tutte 13.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022179 8 25 10 7 13 4 2 28 10 4 36 32
2022/2023374 43 51 38 64 25 46 18 26 45 6 11 1
2023/2024300 6 64 7 14 7 38 23 22 14 10 35 60
2024/2025563 15 20 42 27 37 39 15 25 72 70 132 69
2025/20261.555 209 60 112 168 259 93 280 72 93 108 41 60
Totale 3.509